In vivo, DHA inhibited the tumor growth of ESCC patient-derived xenografts and weakened p-mTOR, p-p70S6K, and p-RPS6 expression in tumor tissues. This evidence concerns the gene RPS6KB1 and esophageal squamous cell carcinoma.